Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza. Abbott TR, Dhamdhere G, Liu Y, Lin X, et al. Cell 2020 Apr 29. pii: S0092-8674(20)30483-9. doi: 10.1016/j.cell.2020.

Read + Share

Amedeo Smart

Independent Medical Education

Abbott TR, Dhamdhere G, Liu Y, Lin X, et al. Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza. Cell 2020 Apr 29. pii: S0092-8674(20)30483-9. doi: 10.1016/j.cell.2020.
PMID: 32353252